Publication

Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses

See how young and geriatric horses show similar phenylbutazone PK profiles, indicating no dose adjustment…

Certara2024 年 6 月 28 日

Publication

Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients

Learn how lorazepam and valproate significantly affect ziprasidone clearance; PopPK modelling supports personalized dosing using…

Certara2024 年 6 月 25 日

刊物

Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.

Find out how gestational and postnatal age drive fluconazole PK variability; PopPK modelling supports tailored…

Certara2024 年 6 月 8 日

Case Study

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…

Certara2024 年 5 月 31 日

Publication

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.

Certara2024 年 3 月 13 日

Publication

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…

Certara2024 年 3 月 4 日

网络研讨会点播

Phoenix 8.5 有哪些新功能？

了解 Phoenix 8.5 版本的最新进展和增强功能。Watch the webinar to learn…

Certara2024 年 2 月 26 日

Publication

Simcyp 群体模拟器中 PBPK 建模复合文件开发指南

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

Certara2024 年 2 月 23 日

Blog

靶向放射治疗的剂量优化考量

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…

Certara2024 年 2 月 16 日

Publication

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…

Certara2024 年 2 月 1 日

建模与模拟

Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses

Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients

Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

Phoenix 8.5 有哪些新功能？

Simcyp 群体模拟器中 PBPK 建模复合文件开发指南

靶向放射治疗的剂量优化考量

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

订阅时事通讯

快捷链接

解决方案

联系我们